Thursday, June 8, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Associate Professor
Infectious Diseases
Faculty of Medicine
Autonomous University of Madrid
Research Director
HIV and Infectious Diseases Unit
Hospital La Paz Institute for Health Research (IdiPAZ)
Madrid, Spain
Consultant Physician in Internal Medicine and Infectious Diseases
Technical University of Munich
School of Medicine
University Hospital Rechts der Isar
Department of Medicine II
Munich, Germany
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Non-US Physicians - maximum of 0.50 CPD
This educational activity is intended for an international audience of non-US primary care physicians, infectious disease/HIV specialists, and pulmonologists.
The goal of this activity is for clinicians to be more knowledgeable about the latest data on and practical considerations for effectively using monoclonal antibodies (mAbs) in clinical practice.
Upon completion of this activity, participants will:
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Associate Professor
Infectious Diseases
Faculty of Medicine
Autonomous University of Madrid
Research Director
HIV and Infectious Diseases Unit
Hospital La Paz Institute for Health Research (IdiPAZ)
Madrid, Spain
Consultant Physician in Internal Medicine and Infectious Diseases
Technical University of Munich
School of Medicine
University Hospital Rechts der Isar
Department of Medicine II
Munich, Germany
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 6/10/2022
Valid for credit through: 6/10/2023
processing....
Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to the approved COVID-19 vaccines are provided in this activity in an effort to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.
The goal of this activity is for clinicians to be more knowledgeable about the latest data on and practical considerations for effectively using monoclonal antibodies (mAbs) in clinical practice.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
